Effect of Compressive Force on the Production of Prostaglandin E₂ and its Receptors in Osteoblastic Saos-2 Cells

REFERENCES

• Krishnan V., Davidovitch Z. Cellular, molecular, and tissue-level reactions to orthodontic force. Am. J. Orthod. Dentofacial Orthop. 2006; 129(469e)1–32
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Shibata Y., Fukuhara T. The effect of prostaglandins on experimental tooth movement in monkeys (Macaca fuscata). J. Dent. Res. 1982; 61: 1444–1446
   PubMed Web of Science ®Google Scholar
• Yamasaki K., Shibata Y., Imai S., Tani Y., Shibasaki Y., Fukuhara T. Clinical application of prostaglandin E1 (PGE1) upon orthodontic tooth movement. Am. J. Orthod. 1984; 85: 508–518
   PubMedGoogle Scholar
• Lee W. Experimental study of the effect of prostaglandin administration on tooth movement—with particular emphasis on the relationship to the method of PGE1 administration. Am. J. Orthod. Dentofacial Orthop. 1990; 98: 231–241
   PubMed Web of Science ®Google Scholar
• Leiker B.J., Nanda R.S., Currier G.F., Howes R.I., Sinha P.K. The effects of exogenous prostaglandins on orthodontic tooth movement in rats. Am. J. Orthod. Dentofacial Orthop. 1995; 108: 380–388
   PubMed Web of Science ®Google Scholar
• Klein D.C., Raisz L.G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology 1970; 86: 1436–1440
   PubMed Web of Science ®Google Scholar
• Rifkin B.R., Baker R.L., Cokeman S.J. Effects of prostaglandin E2 on macrophages and osteoclasts in cultured fetal long bones. Cell Tissue Res. 1980; 207: 341–346
   PubMed Web of Science ®Google Scholar
• Okuda A., Taylor L.M., Heersche J.N. Prostaglandin E2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures. Bone Miner. 1989; 7: 255–266
   PubMedGoogle Scholar
• Tomita M., Li X., Okada Y., Woodiel F.N., Young R.N., Pilbeam C.C., Raisz L.G. Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. Bone 2002; 30: 159–163
   PubMed Web of Science ®Google Scholar
• Akatsu T., Takahashi N., Udagawa N., Imamura K., Yamaguchi A., Sato K., Nagata N., Suda T. Role of prostaglandins in interleukin-1-induced bone resorption in mice in vitro. J. Bone Miner. Res. 1991; 6: 183–189
   PubMed Web of Science ®Google Scholar
• Kale S., Kocadereli I., Atilla P., Asan E. Comparison of the effects of 1,25 dihydroxycholecalciferol and prostaglandin E2 on orthodontic tooth movement. Am. J. Orthod. Dentofacial Orthop. 2004; 125: 607–614
   PubMed Web of Science ®Google Scholar
• Tanabe N., Maeno M., Suzuki N., Fujisaki K., Tanaka H., Ogiso B., Ito K. IL-1α stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. Life Sci. 2005; 77: 615–626
   PubMed Web of Science ®Google Scholar
• Tanaka H., Tanabe N., Shoji M., Suzuki N., Katono T., Sato S., Motohashi M., Maeno M. Nicotine and lipopolysaccharide stimulate the formation of osteoclast-like cells by increasing macrophage colony-stimulating factor and prostaglandin E2 production by osteoblasts. Life Sci. 2006; 78: 1733–1740
   PubMed Web of Science ®Google Scholar
• Shoji M., Tanabe N., Mitsui N., Tanaka H., Suzuki N., Takeichi O., Sugaya A., Maeno M. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sci. 2006; 78: 2012–2018
   PubMed Web of Science ®Google Scholar
• Shoji M., Tanabe N., Mitsui N., Suzuki N., Takeichi O., Katono T., Morozumi A., Maeno M. Lipopolysaccharide enhances the production of nicotine-induced prostaglandin E2 via an increase in cyclooxygenase-2 expression in osteoblasts. Acta Biochim. Biophys. Sin. 2007; 39: 163–172
   Google Scholar
• McCarthy T.L., Centrella M., Raisz L.G., Canalis E. Prostaglandin E2 stimulates insulin-like growth factor I synthesis in osteoblast-enriched cultures from fetal rat bone. Endocrinology 1991; 128: 2895–2900
   PubMed Web of Science ®Google Scholar
• Mano M., Arakawa T., Mano H., Nakagawa M., Kaneda T., Kaneko H., Yamada T., Miyata K., Kiyomura H., Kumegawa H., Hakeda Y. Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif. Tissue Int. 2000; 67: 85–92
   PubMed Web of Science ®Google Scholar
• Mitsui N., Suzuki N., Maeno M., Mayahara K., Yanagisawa M., Otsuka K., Shimizu N. Optimal compressive force induces bone formation via increasing bone sialoprotein and prostaglandin E2 production appropriately. Life Sci. 2005; 77: 3168–3182
   PubMed Web of Science ®Google Scholar
• Suzawa T., Miyaura C., Inada M., Maruyama T., Sugimoto Y., Ushikubi F., Ichikawa A., Narumiya S., Suda T. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs. Endocrinology 2000; 141: 1554–1559
   PubMed Web of Science ®Google Scholar
• Weinreb M., Machwate M., Shir N., Abramovitz M., Rodan G.A., Harada S. Expression of the prostaglandin E2 (PGE2) receptor subtype EP4 and its regulation by PGE2 in osteoblastic cell lines and adult rat bone tissue. Bone 2001; 28: 275–281
   PubMed Web of Science ®Google Scholar
• Sugimoto Y., Namba T., Honda A., Hayashi Y., Negishi M., Ichikawa A., Narumiya S. Cloning and expression of a cDNA for mouse prostaglandin E receptor EP3 subtype. J. Biol. Chem. 1992; 267: 6463–6466
   PubMed Web of Science ®Google Scholar
• Watabe A., Sugimoto Y., Honda A., Irie A., Namba T., Negishi M., Ito S., Narumiya S., Ichikawa A. Cloning and expression of cDNA for a mouse EP1 subtype of prostaglandin E receptor. J. Biol. Chem. 1993; 268: 20175–20178
   PubMed Web of Science ®Google Scholar
• Katsuyama M., Nishigaki N., Sugimoto Y., Morimoto K., Negishi M., Narumiya S., Ichikawa A. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 1995; 372: 151–156
   PubMed Web of Science ®Google Scholar
• Suda M., Tanaka K., Natsui K., Usui T., Tanaka I., Fukushima M., Shigeno C., Konishi J., Narumiya S., Ichikawa A., Nakano K. Prostaglandin E receptor subtypes in mouse osteoblastic cell line. Endocrinology 1996; 137: 1698–1705
   PubMed Web of Science ®Google Scholar
• Li X., Okada Y., Pilbeam C.C., Lorenzo J.A., Kennedy C.R., Breyer R.M., Raisz L.G. Knockout of the murine prostaglandin EP2 receptor impairs osteoclastogenesis in vitro. Endocrinology 2000; 141: 2054–2061
   PubMed Web of Science ®Google Scholar
• Miyaura C., Inada M., Suzawa T., Sugimoto Y., Ushikubi F., Ichikawa A., Narumiya S., Suda T. Impaired bone resorption to prostaglandin E2 in prostaglandin E receptor EP4-knockout mice. J. Biol. Chem. 2000; 275: 19819–19823
   PubMed Web of Science ®Google Scholar
• Sakuma Y., Tanaka K., Suda M., Yasoda A., Natsui K., Tanaka I., Ushikubo F., Narumiya S., Segi E., Sugimoto Y., Ichikawa A., Nakao K. Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide. J. Bone Miner. Res. 2000; 15: 218–227
   PubMed Web of Science ®Google Scholar
• Fogh J., Wright W.C., Loveless J.D. Absence of HeLa cell contamination in 169 cell lines derived from human tumors. J. Natl. Cancer Inst. 1977; 58: 209–214
   PubMed Web of Science ®Google Scholar
• Davidovitch Z., Nicolay O.F., Ngan P.W., Shanfeld J.L. Neurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics. Dent. Clin. North Am. 1988; 32: 411–435
   PubMedGoogle Scholar
• Kanzaki H., Chiba M., Shimizu Y., Mitani H. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J. Bone Miner. Res. 2002; 17: 210–220
   PubMed Web of Science ®Google Scholar
• Miyamoto K., Suzuki H., Yamamoto S., Saitoh Y., Ochial E., Moritani S., Yokogawa K., Waki Y., Kasugai S., Sawanishi H., Yamagami Y. Prostaglandin E2-mediated anabolic effect of a novel inhibitor of phosphodiesterase 4, XT-611, in the in vitro bone marrow culture. J. Bone Miner. Res. 2003; 18: 1471–1477
   PubMed Web of Science ®Google Scholar
• Kanai K., Nohara H., Hanada K. Initial effects of continuously applied compressive stress to human periodontal ligament fibroblasts. J. Jpn. Orthod. Soc. 1992; 51: 153–163
   Google Scholar
• Watanabe K., Saito I., Hanada K. Effects of conditioned medium of continuously compressed human periodontal ligament fibroblasts on MC3T3-E1. J. Jpn. Orthod. Soc. 1998; 57: 173–179
   Google Scholar
• Mitsui N., Suzuki N., Maeno M., Yanagisawa M., Koyama Y., Otsuka K., Shimizu N. Optimal compressive force induces bone formation via increasing bone morphogenetic proteins production and decreasing their antagonists production by Saos-2 cells. Life Sci. 2006; 78: 2697–2706
   PubMed Web of Science ®Google Scholar
• Mitsui N., Suzuki N., Koyama Y., Yanagisawa M., Otsuka K., Shimizu N., Maeno M. Effect of compressive force on the expression of MMPs, PAs, and their inhibitors in osteoblastic Saos-2 cells. Life Sci. 2006; 79: 575–583
   PubMed Web of Science ®Google Scholar
• Zohar R., Suzuki N., Suzuki K., Arora P., Glogauer M., McCulloch C. A.G., Sodek J. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J. Cell. Physiol. 2000; 184: 118–130
   PubMed Web of Science ®Google Scholar
• Raisz L.G. Prostaglandins and bone: physiology and pathophysiology. Osteoarthr. Cartil. 1999; 7: 419–421
   PubMed Web of Science ®Google Scholar
• Okada Y., Lorenzo J. A., Freeman A. M., Tomita M., Morham S.G., Raisz L. G., Pilbean C. C. Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture. J. Clin. Invest. 2000; 105: 823–832
   PubMed Web of Science ®Google Scholar
• Anderson D. M., Maraskovsky E., Billingsley W. L., Dougall W. C., Tometsko M. E., Roux E. R., Teepe M. C., DuBose R. F., Cosman D., Galibert L. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997; 175–179
   PubMed Web of Science ®Google Scholar
• Fuller K., Owens J. M., Jagger C. J., Wilson A., Moss R., Chambers T. J. Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J. Exp. Med. 1993; 178: 1733–1744
   PubMed Web of Science ®Google Scholar
• Jimi E., Shoto T., Koga T. Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells. Endocrinology 1995; 136: 808–811
   PubMed Web of Science ®Google Scholar
• Simonet W. S., Lacey D. L., Dunstan C. R., Kelley M., Chang M. -S., Lüthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 1997; 89: 309–319
   PubMed Web of Science ®Google Scholar
• Kanematsu M., Sato T., Takai H., Watanabe K., Ikeda K., Yamada Y. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency. J. Bone Miner. Res. 2000; 15: 1321–1329
   PubMed Web of Science ®Google Scholar
• Samoto H., Shimizu E., Matsuda-Honjyo Y., Saito R., Nakao S., Yamazaki M., Furuyama S., Sugiya H., Sodek Y., Ogata Y. Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene. J. Biol. Chem. 2003; 278: 28659–28667
   PubMed Web of Science ®Google Scholar